MKI67 and inflammatory breast carcinoma: In our cohort (n = 357), we chose the hotspot method (Figures 7A–F) and calculated Ki67 ratios as a continuous variable rather than a categorical variable in accordance with the current local and national guidelines for the diagnosis, treatment, and follow-up of patients with IBC (58).